Hawthorne Effect Founder + CEO
The Venture, Innovation, & Partnering Conference was a one-day conference focused on innovation in the clinical trials space and brings together investment executives, CROs, pharmaceutical strategics, and venture and corporate firms that are innovating in the medical research space. The full agenda included a full slate of discussions and roundtables on the intersection of clinical trials innovation and investment opportunities.
This conference was presented in conjunction with the 14th annual SCOPE Summit, held February 6-9, 2023 at Rosen Shingle Creek in Orlando, FL. SCOPE focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations.
Jodi Akin, Hawthorne Effect Founder + CEO, spoke on multiple panels, and the rest of the Hawthorne team was present to discuss how we accelerate clinical trials and unlock patient access.
Hawthorne Effect goes beyond traditional decentralized clinical trials (DCT) models and takes the trial directly to the patient in their home.
HIPAA-compliant and cloud-based SaaS solution
ACT™ provides four key components to manage the clinical trial journey among researchers, clinicians, and trial participants.
Collaboration and flexibility for KOLs and sponsors
Our four-phase plan combines the ACT™ platform with our network of Heroes and a robust playbook of adaptive processes.
2,500+ Heroes, 50 states, 20K+ visits, millions of assessments
The Hawthorne Network of Heroes represents a broad spectrum of therapeutic areas work and live where the trial is taking place.